ArticleJAMA2018
Screening for Ovarian Cancer in Asymptomatic Women.
Article in JAMA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03622385 (Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022Pooled it
- Radiomics-based MRI model for differentiating ovarian cystadenoma and cystadenocarcinoma.Frontiers in oncology · 2026Article
- Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice.Cancer immunology, immunotherapy : CII · 2025Article
- Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer.Current oncology (Toronto, Ont.) · 2024Review
- Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.British journal of cancer · 2024Article
- Decoding the glycoproteome: a new frontier for biomarker discovery in cancer.Journal of hematology & oncology · 2024Review
- Serum hsa_circ_0007534 as a diagnostic biomarker for ovarian cancer.American journal of translational research · 2024Article
- MicroRNA-409-5p inhibits cell proliferation, and induces GOncology letters · 2022Article
- Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer.Cancer management and research · 2021Article
- Proline-rich protein 11 overexpression is associated with a more aggressive phenotype and poor overall survival in ovarian cancer patients.World journal of surgical oncology · 2020Article
- Characterization of miR-200 family members as blood biomarkers for human and laying hen ovarian cancer.Scientific reports · 2020Article
- Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma.Gynecologic oncology · 2020Article
- Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.OncoTargets and therapy · 2019Article
- Urine Biomarkers for the Early Detection of Ovarian Cancer - Are We There Yet?Biomarkers in cancer · 2019Review
- Article
- Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review.Indian journal of clinical biochemistry : IJCB · 2018Review
- Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.The British journal of radiology · 2018Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
29450509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.